SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets closed

Sanofi (SNY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.35+0.18 (+0.45%)
At close: 4:02PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close40.17
Bid0.00 x
Ask0.00 x
Day's Range40.23 - 40.58
52 Week Range36.81 - 44.50
Avg. Volume2,203,803
Market Cap100.95B
PE Ratio (TTM)23.45
Earnings DateN/A
Dividend & Yield1.66 (4.12%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 days ago

    Sanofi's M&A misses frustrate some investors in drugmaker

    PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors. In an interview at the World Economic Forum in the Swiss resort of Davos this week Brandicourt defended his track record, citing an unwillingness to overpay for pricey assets and a paucity of good opportunities.

  • MannKind Has a New Plan, but Will It Work?
    Motley Fool4 days ago

    MannKind Has a New Plan, but Will It Work?

    MannKind plans to more than double its sales force and air TV commercials plus more to increase Afrezza sales. Will this plan work?

  • Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval
    Zacks4 days ago

    Sanofi Diabetes Drug Suliqua Wins EU Marketing Approval

    Sanofi (SNY) announced that the European Commission has granted marketing authorization to its once-daily injection, Suliqua a combination of diabetes drugs Lantus and lixisenatide for the treatment of diabetes.